Home › Funds › Vestal Point Capital, LP › INSM
Vestal Point Capital, LP position in INSM
INSMED INC · Health Care
Vestal Point Capital, LP reported holding 2,725,000 shares of INSM (INSMED INC) in its Q3 2026 13F filing — a position valued at US$311.0M, representing 8.04% of its reported portfolio and ranking #5 among its reported holdings. Vestal Point Capital, LP has disclosed INSM holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Vestal Point Capital, LP's INSM position evolved
Vestal Point Capital, LP first disclosed a stake in INSM in Q4 2023 at 900,000 shares (US$27.9M). The position peaked in Q3 2026 at 2,725,000 shares, worth US$311.0M. Across 8 filings, Vestal Point Capital, LP increased the stake 3 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,725,000 shares valued at US$311.0M — an increase of 2,475,000 shares quarter over quarter.. Notable position changes include a 113% increase in Q3 2024 (shares fell 5% over the following quarter), a 44% trim in Q4 2024 (shares rose 11% over the following quarter), a 990% increase in Q3 2026 (shares rose 8% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2023 | 900.00K | $27.89M | New |
| Q1 2024 | 750.00K | $20.35M | Reduce |
| Q2 2024 | 750.00K | $50.25M | Hold |
| Q3 2024 | 1.60M | $116.80M | Add |
| Q4 2024 | 900.00K | $62.14M | Reduce |
| Q1 2025 | 1.07M | $82.01M | Add |
| Q2 2026 | 250.00K | $26.66M | New |
| Q3 2026 | 2.73M | $311.03M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About INSM and 13F data
INSM (INSMED INC) is a Health Care company. 41 other funds we track also report a position in INSM — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.00B), Orbis Allan Gray Ltd (US$768.6M), Artisan Partners Limited Partnership (US$636.7M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding INSM
- BAKER BROS. ADVISORS LP 8.80M sh · $1.00B · Q3 2026
- Orbis Allan Gray Ltd 6.73M sh · $768.62M · Q3 2026
- Artisan Partners Limited Partnership 5.58M sh · $636.68M · Q3 2026
- D. E. Shaw & Co 5.94M sh · $633.12M · Q2 2026
- RTW INVESTMENTS, LP 3.10M sh · $353.44M · Q3 2026
- Paradigm Biocapital Advisors LP 2.70M sh · $307.72M · Q3 2026
- Castle Hook Partners LP 2.56M sh · $291.86M · Q3 2026
- MAVERICK CAPITAL LTD 2.52M sh · $287.83M · Q3 2026
- Maverick Capital 2.15M sh · $229.31M · Q2 2026
- Polar Capital Holdings Plc 1.75M sh · $200.17M · Q3 2026
- WESTFIELD CAPITAL MANAGEMENT CO LP 1.55M sh · $177.20M · Q3 2026
- Bellevue Group AG 1.51M sh · $172.13M · Q3 2026
More on Vestal Point Capital, LP
FAQ
How long has Vestal Point Capital, LP held INSM?
Vestal Point Capital, LP has disclosed INSM holdings in 8 of the last 12 reported quarters, going back to Q4 2023.
What is Vestal Point Capital, LP's current position in INSM?
As of Q3 2026, Vestal Point Capital, LP holds 2.73M shares of INSM (INSMED INC), valued at $311.03M, representing 8.04% of its reported portfolio and ranking #5.
Has Vestal Point Capital, LP been buying or selling INSM?
In the latest 13F filing (Q3 2026), Vestal Point Capital, LP increased its position in INSM. The position peaked in Q3 2026 at 2.73M shares.
Which other funds hold INSM?
Other major institutional holders of INSM include BAKER BROS. ADVISORS LP, Orbis Allan Gray Ltd, Artisan Partners Limited Partnership, among 41 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.